Aspirin Market
Aspirin Market Size, Share & Trends Analysis Report by Route of Administration (Oral, Rectal, Parenteral), by Dosage Form (Tablets, Intravenous Injections, Capsules, and Others), by Applications (Pain, Deep vein Thrombosis, Fever and Inflammation and Others), by Product Type (Alone, Combination Products), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Forecast Period (2023-2030) Update Available - Forecast 2024-2030
Aspirin market is anticipated to grow at a CAGR of 3.6% during the forecast period (2023-2030). Effective analgesics such as aspirin can aid with pain management. Aspirin can prevent platelet aggregation, it can reduce the likelihood that blood clots will form. Due to its antiplatelet effect, Aspirin is used as a preventive measure for certain cardiovascular diseases it can help reduce the risk of blood clot formation in the arteries, preventing blockages that can lead to heart attack or stroke. Aspirin plays an important role in reducing the risk of cancer such as breast cancer, prostate cancer, lung cancer, and ovarian cancer. For Instance, according to the National Institute of Health (NIH), Aspirin frequently lowers the risk of developing ovarian cancer, however, it is unclear whether hereditary variables affect this link. Understanding impact modifiers is crucial since any aspirin usage for ovarian cancer chemoprevention will probably need to concentrate on particular higher-risk subgroups. The administration of antiplatelet drugs to treat Alzheimer's disease, including aspirin and clopidogrel. While the antiplatelet effects of these drugs are frequently prescribed to treat illnesses like heart disease, stroke, and Alzheimer's disease by preventing the formation of clots. For Instance, in January 2023, FDA granted expedited approval to LEQEMBITM (lecanemab-irmb) for the treatment of Alzheimer's disease. Aspirin and clopidogrel are examples of antiplatelet medicines that are permitted. individuals who received both LEQEMBI and an antithrombotic drug.
Segmental Outlook
The global aspirin market is segmented by route of administration, dosage form, application, product and distribution channel. Based on the route of administration the market is sub-segmented into oral, rectal, and parenteral. Based on the dosage form, the market is sub-segmented into tablets, intravenous injections, capsules, and others (syrup). Based on the application, the market is sub-segmented into pain, deep vein thrombosis, fever and inflammation and others. Based on the product type, the market is bifurcated into alone and combination. Furthermore, on the basis of the distribution channel the market is sub-segmented into hospitals pharmacies, retail pharmacies, and online pharmacies. Among the dosage forms tablets and capsules sub-segment is anticipated to hold a considerable share of the market owing to the rise in the development of market growth.
The Retail Pharmacies Sub-Segment is Anticipated to Hold a Considerable Share of the Global Aspirin Market
Among the distribution channel, the retail sub-segment is expected to hold a considerable share of the global aspirin market. Aspirin is frequently found in pharmaceuticals that can be purchased both retail and online. It is primarily utilized for its analgesic, antipyretic, and anti-inflammatory effects. Its retail applications include over-the-counter (OTC) sales, self-medication, and cardiovascular health. Aspirin can be easily purchased online from the comfort of one's home. Online usage offers accessibility, ease, and large-scale purchasing. Healthcare professionals advise aspirin use for people who are at high risk for cardiovascular events, such as heart attacks and strokes, two prevalent cardiovascular conditions that aspirin is regularly used to treat and prevent. As these illnesses are becoming increasingly commonplace globally, aspirin is gaining popularity as a therapeutic and preventive tool. Therefore, the rise in the prevalence of heart disorders is a key factor in the market's expansion. For Instance, in July 2023, Techfields Pharma is currently conducting clinical research on aspirin trelamine hydrochloride. Treatment for type 2 diabetes, myocardial infarction, pulmonary embolism, and chronic heart failure includes aspirin trelamine hydrochloride. It is administered both topically as a powder for a solution and transdermal as a spray.
Regional Outlook
The global aspirin market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market across the globe, owing to the high concentration of the market solution vendors including Nanjing Pharma techs Co, ltd., JQC (Huayin) Pharmaceutical Co., Ltd., Globela Pharma Pvt Ltd, Trumac Healthcare, Alta Laboratories Ltd, Zhenjiang Gaopeng Pharmaceutical CO, Ltd., and others.
Global Aspirin Market Growth, by Region 2023-2030
North America is Expected to Grow at a Significant CAGR in the Global Aspirin Market
North America is is expected to grow at a significant CAGR over the forecast period, owing to the high prevalence of cardiovascular diseases (CVDs) and the increasing demand for aspirin for pain management. According to the National Institute of Health (NIH), Aspirin use was significantly associated with a decreased risk caused due to mortality among COVID-19 individuals. Aspirin's function in primary prevention is also discussed in current recommendations. As a technique for the secondary prevention of cardiovascular events, aspirin treatment is well-acknowledged. For Instance, in July 2023, Dr. Reddy's Laboratories Ltd. launched a well-liked statin and dual antiplatelet formulation under the trade name ROZAT GOLD. Rozat Gold is recommended for use in patients with high-risk cardiovascular conditions such as chronic and stable coronary illnesses by cardiologists, consulting physicians, and diabetologists.
Market Players Outlook
The major companies serving the aspirin market include Allegiant Health, Par Pharmaceutical, St. Joseph's Aspirin, Thermo Fisher Scientific Inc., Chemische Fabrik Weyl GmbH, Eli Lilly, Lohmann LTS, and Upjohn Co. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2022, Bayer AG brand Alka-Seltzer®, known for its effervescent antacids and painkillers, collaborated with the producer and musician T-Pain to introduce its newest product, NEW Alka-Seltzer hangover relief. The drug contains high-strength aspirin and caffeine, thus, advised to consumer only two drops in a glass of water forquick relief.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global aspirin market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Bayer AG
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Cardinal Health
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. LNK International, Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Aspirin Market by Route of Administration
4.1.1. Oral
4.1.2. Rectal
4.1.3. Parenteral
4.2. Global Aspirin Market by Dosage Form
4.2.1. Tablets
4.2.2. Intravenous Injections
4.2.3. Capsules
4.2.4. Syrups
4.2.5. Others (Extended Release, Delayed Release, Chewable)
4.3. Global Aspirin Market by Applications
4.3.1. Pain
4.3.2. Deep vein Thrombosis
4.3.3. Fever and Inflammation
4.3.4. Others
4.4. Global Aspirin Market by Product Type
4.4.1. Alone
4.4.2. Combination Products
4.5. Global Aspirin Market by Distribution Channel
4.5.1. Hospitals Pharmacies
4.5.2. Retail Pharmacies
4.5.3. Online pharmacies
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Advance Pharmaceutical Inc.
6.2. Alta laboratories Ltd.
6.3. Endo International plc
6.4. Globalimpoter Inc.
6.5. Globela Pharma Pvt Ltd.
6.6. J.M Loveridge Ltd.
6.7. JQC (Huayin) Pharmaceutical co., Ltd.
6.8. Nanjing Pharmatechs Co., Ltd.
6.9. Perrigo Company plc
6.10. Seqens
6.11. St. Joseph Aspirin
6.12. Thermo fisher scientific
6.13. Trumac Healthcare
6.14. Umang Pharmatechs co,.Ltd.
6.15. Zhenjiang Gaopeng Pharmaceutical co,.Ltd.
1. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)2022-2030 ($ MILLION)
2. GLOBAL ORAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
3. GLOBAL RECTAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
4. GLOBAL PARENTENAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
5. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
6. GLOBAL ASPIRIN IN TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL ASPIRIN IN INTRAVENOUS INJECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
8. GLOBAL ASPIRIN IN CAPSULES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL ASPIRIN IN OTHER FORMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
10. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
11. GLOBAL ASPIRIN FOR PAIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022–2030 ($ MILLION)
12. GLOBAL ASPIRIN FOR DEEP VEIN THROMBOSIS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022–2030 ($ MILLION)
13. GLOBAL ASPIRIN FOR FEVER AND INFLAMMATION MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022–2030 ($ MILLION)
14. GLOBAL ASPIRIN FOR OTHER TREATMENTS MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022–2030 ($ MILLION)
15. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
16. GLOBAL ASPIRIN IN ALONE MARKET RESEARCH AND ANALYSIS BY REGION, 2022–2030 ($ MILLION)
17. GLOBAL ASPIRIN IN COMBINATION PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2022–2030 ($ MILLION)
18. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
19. GLOBAL ASPIRIN IN HOSPITALS PHARMACIES MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
20. GLOBAL ASPIRIN IN RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
21. GLOBAL ASPIRIN IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
22. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
23. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
24. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
25. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
26. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
27. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
28. NORTH AMERICAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
29. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
30. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
31. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
32. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
33. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
34. EUROPEAN ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
35. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
36. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
37. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
38. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
39. ASIA-PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
40. ASIA- PACIFIC ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
41. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2022-2030 ($ MILLION)
42. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022-2030 ($ MILLION)
43. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
44. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022-2030 ($ MILLION)
45. REST OF THE WORLD ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNNEL, 2022-2030 ($ MILLION)
1. GLOBAL ASPIRIN MARKET SHARE BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
2. GLOBAL ORAL ASPIRIN MARKET SHARE BY REGION, 2022 VS 2030 (%)
3. GLOBAL RECTAL ASPIRIN MARKET SHARE BY REGION, 2022 VS 2030 (%)
4. GLOBAL PARENTENAL ASPIRIN MARKET SHARE BY REGION, 2022 VS 2030 (%)
5. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DOSAGE FORM, 2022 VS 2030 (%)
6. GLOBAL ASPIRIN IN TABLETS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
7. GLOBAL ASPIRIN IN INTRAVENOUS INJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
8. GLOBAL ASPIRIN IN CAPSULES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
9. GLOBAL ASPIRIN IN OTHERS FORMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
10. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022 VS 2030 (%)
11. GLOBAL ASPIRIN FOR PAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
12. GLOBAL ASPIRIN FOR DEEP VEIN THROMBOSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
13. GLOBAL ASPIRIN FOR FEVER AND INFLAMMATION MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
14. GLOBAL ASPIRIN FOR OTHER TREATMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
15. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2022 VS 2030 (%)
16. GLOBAL ASPIRIN IN ALONE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
17. GLOBAL ASPIRIN IN COMBINATION PRODUCT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
18. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
19. GLOBAL ASPIRIN IN HOSPITALS PHARMACIES MARKET RESEARCH AND ANALYSIS 2022 VS 2030 (%)
20. GLOBAL ASPIRIN IN RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS 2022 VS 2030 (%)
21. GLOBAL ASPIRIN IN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS 2022 VS 2030 (%)
22. GLOBAL ASPIRIN MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
23. US ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
24. CANADA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
25. UK ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
26. FRANCE ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
27. GERMANY ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
28. ITALY ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
29. SPAIN ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
30. REST OF EUROPE ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
31. INDIA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
32. CHINA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
33. JAPAN ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
34. SOUTH KOREA ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
35. REST OF ASIA-PACIFIC ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
36. REST OF THE WORLD ASPIRIN MARKET SIZE, 2022-2030 ($ MILLION)
